Running discussion on SP, page-51

Interesting comparison, I would disagree, I think they have performed similarly in that regard, if not in SP performance.

When I first invested in the other, they were to have the full scale plant up and running by 2023, yet we are still waiting on offtakes and finance. Now, that is not a complaint, companies are always optimistic and commercial timelines nearly always drag out. The other has also adjusted their strategy multiple times in the past few years to take advantage of their evolving opportunities, as has CXL.

I think the key difference is the other has one market and a defined project, whereas CXL has far more potential, but with no exciting well defined commercial scale project (the lithium JV is in a market with poor sentiment and without the robust DFS and look through to commercial performance) . This variance allowed CXL to gain a far higher market cap when sentiment and momentum was with it, it is also the reason for the slide when those forces subsided.

All IMO, please DYOR and GLTAH.